CIK: 935679 - Address: C/o Agenus Inc., 3 Forbes Road, Lexington, MA 02421
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111746423511-116
P%wins82719488695777

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/15/24 18:59
2/15/24
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMADOSee RemaP3240.64810500262,436I
5/4/23 19:47
5/2/23
INKTMink Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYDP950.9485010051,978D
10/31/17 10:08
10/27/17
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMAOCB,CEOP.am3553.55010071,594D
4/12/17 17:41
4/10/17
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMADOCB,CEOP.m3353.35410081,423D-42-25-55-21-24-16-14-37515
8/18/16 16:35
6/17/16
ATRNDProtagenic Therapeutics, Inc.newDEBizSvBizSvBusiness ServicesArmen Garo HNYDOTSee RemaP751.2506014,299D
5/10/16 09:49
5/6/16
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMAOCB,CEOP.am3183.18410081,396D32-52-2815-20-22-14128298722
5/10/16 09:22
5/5/16
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMAOCB,CEOP.m3183.18410081,396D32-52-2815-20-22-14128298722
3/8/16 11:35
3/7/16
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMAOCB,CEOP8064.034200191,251D-14-20-40-1221374928-1-214849-6
9/29/15 20:19
9/25/15
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HMAOCB,CEOP5035.03810061,714D6355-11-43-41-36-35-244974-760
10/3/11 11:19
9/30/11
AGENDAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP502.9901711,746D
8/17/11 08:35
8/16/11
AGENAgenus IncDEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP1,0970.510002,1512610,317D-73-27-41-41-33-29-7-24-70-23-438
6/29/09 10:31
6/25/09
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP491.97325013,818D-377345282183-9-93-2-46011-62-53
1/11/08 15:25
1/9/08
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP5,1263.0001,7091413,533M-5118-16-12915171134-99-28-79
9/14/07 17:31
9/14/07
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP1172.33050011,756D-573316-27-210-304-223-13-8-36
3/16/07 09:05
3/15/07
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP202.03010011,706D-73-681513514100122591614
3/14/07 16:02
3/13/07
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP.m502.00025011,696D-73-6814-4-2-412101-273561414
3/13/07 07:47
3/12/07
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP481.91025011,671D-71-6817-12-11113-306655168
3/12/07 08:23
3/8/07
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCB,CEOP.m911.83050011,646D-74-72-2-13-9-14-411214103783727
2/13/07 13:21
2/9/07
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYOCEO,CBP971.93050011,596D-76-6320-135-4-13544184117
10/28/04 07:46
10/27/04
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYDOCB,CEOP1606.39125011,494I-31-43-36-9-3711177236259-16
10/25/04 16:33
10/22/04
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYDOCB,CEOP.m2795.58150011,469I-36-55-44-21-16-10-514921523122-8
10/21/04 15:53
10/21/04
AGENAntigenics Inc /de/DEHealthBioPrdBiological Products, (No DiagArmen Garo HNYDOCB,CEOP4744.740100111,414I-48-62-53-38-26-22-25-1973888724213

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact